Josie Zayner: The Perils of Unregulated BiohackingJosie Zayner's self-experimentation raises significant ethical and safety concerns in biohacking, highlighting the risks of unregulated genetic engineering.
Your Next Pet Could Be a Glowing RabbitThe Los Angeles Project seeks to genetically engineer pets like glow-in-the-dark rabbits and hypoallergenic dogs, guided by biohacker Josie Zayner.
A Rose Without Thorns? How Gene Editing Is Giving Plants A Glow-UpThe discovery of a gene controlling prickliness can lead to the development of smooth, prickle-free plants without compromising fruit and flower quality.
The company that created woolly mice announces the de-extinction' of the dire wolfColossal Biosciences has reportedly de-extincted the dire wolf using genetic engineering techniques.
Josie Zayner: The Perils of Unregulated BiohackingJosie Zayner's self-experimentation raises significant ethical and safety concerns in biohacking, highlighting the risks of unregulated genetic engineering.
Your Next Pet Could Be a Glowing RabbitThe Los Angeles Project seeks to genetically engineer pets like glow-in-the-dark rabbits and hypoallergenic dogs, guided by biohacker Josie Zayner.
A Rose Without Thorns? How Gene Editing Is Giving Plants A Glow-UpThe discovery of a gene controlling prickliness can lead to the development of smooth, prickle-free plants without compromising fruit and flower quality.
The company that created woolly mice announces the de-extinction' of the dire wolfColossal Biosciences has reportedly de-extincted the dire wolf using genetic engineering techniques.
Scientist Who Gene-Hacked Human Babies Says Ethics Are "Holding Back" Scientific ProgressHe Jiankui argues that ethics restrains scientific innovation, claiming that his controversial actions in gene editing should not dissuade progress.
Who gets ownership of useful genetic data?Digital sequence information (DSI) from genetic resources like Cow D propels advancements in research, leading to breakthroughs like new gene-editing therapies.
Bay Area biotech company that raised $66 million shuts downSpotlight Therapeutics has closed down due to inadequate research outcomes and ongoing financial challenges.
CRISPR genome-editing grows up: advanced therapies head for the clinicGene-editing therapies like Casgevy show long-lasting benefits for blood disorders but face challenges in accessibility due to complexity and cost.
No CRISPR: oddball 'jumping gene' enzyme edits genomes without breaking DNAA molecular oddity in bacteria could lead to precise genome redesign through jumping genes, surpassing CRISPR limitations.
Jennifer Doudna on the Brave New World Being Ushered In by Gene EditingCRISPR technology offers transformative potential for medicine and agriculture but raises significant ethical and societal concerns.
Scientist Who Gene-Hacked Human Babies Says Ethics Are "Holding Back" Scientific ProgressHe Jiankui argues that ethics restrains scientific innovation, claiming that his controversial actions in gene editing should not dissuade progress.
Who gets ownership of useful genetic data?Digital sequence information (DSI) from genetic resources like Cow D propels advancements in research, leading to breakthroughs like new gene-editing therapies.
Bay Area biotech company that raised $66 million shuts downSpotlight Therapeutics has closed down due to inadequate research outcomes and ongoing financial challenges.
CRISPR genome-editing grows up: advanced therapies head for the clinicGene-editing therapies like Casgevy show long-lasting benefits for blood disorders but face challenges in accessibility due to complexity and cost.
No CRISPR: oddball 'jumping gene' enzyme edits genomes without breaking DNAA molecular oddity in bacteria could lead to precise genome redesign through jumping genes, surpassing CRISPR limitations.
Jennifer Doudna on the Brave New World Being Ushered In by Gene EditingCRISPR technology offers transformative potential for medicine and agriculture but raises significant ethical and societal concerns.
On a quest to revive the woolly mammoth, Colossal Biosciences has created a woolly mouse | TechCrunchColossal Biosciences is progressing in its effort to resurrect the woolly mammoth by creating genetically engineered mice with mammoth-like fur.
Correcting Genetic Spelling Errors With Next-Generation CrisprSam Berns' life epitomizes the urgent need for advancements in genetic treatments, particularly for disorders like progeria that code for rapid aging.
Daily briefing: Big tomatoes get sweeter thanks to CRISPR editingGenetic modifications can significantly enhance the sweetness of tomatoes without altering their size.Mobile phone data can improve the mapping and understanding of the ionosphere and navigation systems.
On a quest to revive the woolly mammoth, Colossal Biosciences has created a woolly mouse | TechCrunchColossal Biosciences is progressing in its effort to resurrect the woolly mammoth by creating genetically engineered mice with mammoth-like fur.
Correcting Genetic Spelling Errors With Next-Generation CrisprSam Berns' life epitomizes the urgent need for advancements in genetic treatments, particularly for disorders like progeria that code for rapid aging.
Daily briefing: Big tomatoes get sweeter thanks to CRISPR editingGenetic modifications can significantly enhance the sweetness of tomatoes without altering their size.Mobile phone data can improve the mapping and understanding of the ionosphere and navigation systems.
Reprogramming Compromised Immune Cells to Fight Cancer - News CenterResearchers have found a way to reprogram immune cells to combat tumors by targeting specific signaling proteins.Inhibiting proteins AhR and IRAK1 can help convert pro-tumor macrophages back into anti-tumor cells.
The Most Important Breakthroughs of 20242023 highlights include breakthroughs in gene therapy for sickle-cell anemia and a new HIV prevention drug that shows remarkable efficacy.
CRISPR therapy restores some vision to people with blindnessCRISPR-based gene therapy improved vision in individuals with inherited blindness.
The Most Important Breakthroughs of 20242023 highlights include breakthroughs in gene therapy for sickle-cell anemia and a new HIV prevention drug that shows remarkable efficacy.
CRISPR therapy restores some vision to people with blindnessCRISPR-based gene therapy improved vision in individuals with inherited blindness.
Daily briefing: How synthetic 'mirror life' bacteria could infect the worldElon Musk's influence on US science could lead to budget cuts that may hinder innovation.New CRISPR treatment shows long-term potential but raises accessibility concerns.The creation of synthetic organisms with reversed handedness poses ecological risks.
Combining AI and Crispr Will Be TransformationalAI and machine learning are set to enhance Crispr genome editing's impact across multiple fields by 2025.
Scientists Made a CRISPR Breakthrough for Autoimmune DiseasesPromising CRISPR treatments using donor cells may revolutionize the management of autoimmune conditions for millions of Americans.
Crispr-Enhanced Viruses Are Being Deployed Against UTIsLocus's phage therapy effectively targets and degrades E. coli bacteria, showing promising results in treating urinary tract infections (UTIs).
Leadership essentials: "Inspire, motivate, and cultivate"Scribe Therapeutics, led by CEO Benjamin Oakes, aims to revolutionize genetic medicine through innovative genome editing technology.
Rat Neurons Repair Mouse Brains That Lack a Sense of SmellChimeras in the form of mice with rat neurons exhibit brain adaptability for potential disease study and tissue transplantation.